Paul Carpenter, MB.BS

Department of Pediatrics
University of Washington
Clinical Director Pediatric Blood and Marrow Transplant Program
Seattle Cancer Care Alliance

Education:

B.Sc. Medicine, University of Sydney, Australia
MB.BS., Medicine and Surgery, University of Sydney, Australia

Research Focus:

Dr. Carpenter’s research focus is on acute and chronic graft-vs.-host disease (GVHD), the amelioration of long-term complications associated with GVHD therapies, and the prevention of relapse after transplant in the context of continued immunosuppressive therapy.

Clinical Expertise:

  • Acute GVHD
  • Chronic GVHD
  • Long-term Follow-up of hematologic cell transplant (HCT) survivors

Current Studies

Dr. Carpenter is participating in a multi-site trial that will collect and analyze samples from pediatric HCT patients in order to validate biomarkers of acute and chronic GVHD.  Enrollment recently completed on a phase I/II clinical trial to determine if giving patients nilotinib 100 days after HCT is effective in reducing relapse in patients with Philadelphia chromosome-positive leukemias.   Data analysis is beginning on a national multicenter trial he is leading that compared two chronic graft-versus-host disease drug regimens.



Paul Carpenter

Contact Information

Phone
(206) 667-5191
Fax
(206) 667-1034
Email
Additional contact

Mail Stop: D5-290